Photocure ASA - Extraordinary general meeting held

Published: 28 July 2021Medical congresses & eventsFinancial Investment & Stock

Oslo, Norway, 28 July 2021: Photocure ASA (OSE: PHO), held an extraordinary general meeting on 28 July 2021 at 17:00 hours (CEST).

All proposals were resolved as presented in the notice convening the extraordinary general meeting dated 7 July 2021, including the election of Robert Blatt as new member of the nomination committee. The minutes from the general meeting are attached hereto.

For further information, please contact:

CFO Erik Dahl
Tel: +47 450 55 000

About Photocure ASA:
The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO).  For more information, please visit us at, or

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

News and events